Re: you won’t see anyone buying this
in response to
by
posted on
Dec 06, 2023 11:56AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Thanks KK2. 36% dilution over the last 2 years alone. That means every royalty distribution will be more than 1/3 less forever. That's assuming we have salable drugs that hit the market.
tada